Search
for
Sort by
Research 451–480 of 1000+
- Pantolactams as androgen receptor antagonists for the topical suppression of sebum production
- At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors
- Comment on “Androgens and women: COVID‐19 outcomes in women with acne vulgaris, polycystic ovarian syndrome, and hirsutism”
- Aromatase inhibitor–induced hair loss in two adolescents
- Sex differences in COVID-19: the role of androgens in disease severity and progression
- Dermatology of androgen-related disorders
- A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia
- Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships
- Androgens and androgen receptor action in skin and hair follicles
- Hair follicle stem cell differentiation is inhibited through cross‐talk between Wnt/β‐catenin and androgen signalling in dermal papilla cells from patients with androgenetic alopecia
- Nonsteroidal inhibitors of human type I steroid 5-.alpha.-reductase
- Androgens and Female Sexual Function and Dysfunction—Findings From the Fourth International Consultation of Sexual Medicine
- Androgen receptors and their biology
- An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- 5α-Reductase inhibitors in androgenetic alopecia
- Novel Lead Generation through Hypothetical Pharmacophore Three-Dimensional Database Searching: Discovery of Isoflavonoids as Nonsteroidal Inhibitors of Rat 5α-Reductase
- Androgen antagonists in androgen target tissues
- Prescribing testosterone and DHEA: The role of androgens in women
- Changes of androgens levels in menopausal women
- Evaluation of New Pregnane Derivatives as 5.ALPHA.-Reductase Inhibitor.
- Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors
- Anti-Androgen Effects of Extracts and Compounds from<i>Ganoderma lucidum</i>
- Chapter 17. Selective androgen receptor modulators (SARMs)
- 5α-Reductase Inhibitors, Chemical and Clinical Models
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- 5α-Reductase Inhibitors (5ARIs) and Male Reproduction
- Androgen Receptor Actions Modify Skin Structure and Chemical Carcinogen-induced Skin Cancer Susceptibility in Mice
- Prostate-Sparing Effects in Primates of the Potent Androgen 7α-Methyl-19-Nortestosterone: A Potential Alternative to Testosterone for Androgen Replacement and Male Contraception1